InChI=1S/C15H21NO2/c1-2-7-16-8-9-18-15-13-10-12(17)5-3-11(13)4-6-14(15)16/h3,5,10,14-15,17H,2,4,6-9H2,1H3/t14-,15-/m1/s1 |
JCSREICEMHWFAY-HUUCEWRRSA-N |
[H][C@@]12CCC3=C(C=C(O)C=C3)[C@@]1([H])OCCN2CCC |
|
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
|
|
dopamine agonist
A drug that binds to and activates dopamine receptors.
|
|
antiparkinson drug
A drug used in the treatment of Parkinson's disease.
dopamine agonist
A drug that binds to and activates dopamine receptors.
anticonvulsant
A drug used to prevent seizures or reduce their severity.
|
|
View more via ChEBI Ontology
(4aR,10bR)-4-propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol
|
naxagolida
|
WHO MedNet
|
naxagolide
|
WHO MedNet
|
naxagolide
|
WHO MedNet
|
naxagolidum
|
WHO MedNet
|
(+)-4-propyl-9-hydroxynaphthoxazine
|
ChemIDplus
|
(+)-PHNO
|
ChemIDplus
|
(4aR-trans)-3,4,4a,5,6,10b-hexahydro-4-propyl-2H-naphth[1,2-b]-1,4-oxazin-9-ol
|
ChemIDplus
|
dopazinol
|
ChemIDplus
|
nazagolide
|
ChemIDplus
|
PHNO
|
ChEBI
|
88058-88-2
|
CAS Registry Number
|
ChemIDplus
|
10956195
|
PubMed citation
|
Europe PMC
|
11105937
|
PubMed citation
|
Europe PMC
|
15646539
|
PubMed citation
|
Europe PMC
|
15943487
|
PubMed citation
|
Europe PMC
|
1681090
|
PubMed citation
|
Europe PMC
|
1840645
|
PubMed citation
|
Europe PMC
|
19635669
|
PubMed citation
|
Europe PMC
|
2140595
|
PubMed citation
|
Europe PMC
|
24325578
|
PubMed citation
|
Europe PMC
|
2904649
|
PubMed citation
|
SUBMITTER
|
3758188
|
PubMed citation
|
Europe PMC
|
6433000
|
PubMed citation
|
Europe PMC
|
8078498
|
PubMed citation
|
SUBMITTER
|
8301582
|
PubMed citation
|
Europe PMC
|
|